Differentiating cholangiocarcinoma from other diseases

Cholangiocarcinoma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Cholangiocarcinoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Differentiating cholangiocarcinoma from other diseases On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Differentiating cholangiocarcinoma from other diseases All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Differentiating cholangiocarcinoma from other diseases
CDC on Differentiating cholangiocarcinoma from other diseases
Differentiating cholangiocarcinoma from other diseases in the news
Blogs on Differentiating cholangiocarcinoma from other diseases
Directions to Hospitals Treating Cholangiocarcinoma
Risk calculators and risk factors for Differentiating cholangiocarcinoma from other diseases

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Cholangiocarcinoma must be differentiated from other diseases that cause jaundice, abdominal pain, weight loss, and fatigue , such as gallbladder cancer,hepatocellular Carcinoma, pancreatic cancer, cholecystitis, and choledochitis.

Differentiating cholangiocarcinoma from other diseases

Cholangiocarcinoma must be differentiated from other diseases that cause jaundice, abdominal pain, weight loss, and fatigue , such as:

• Gallbladder cancer
• Hepatocellular Carcinoma
• Pancreatic cancer
• Cholecystitis
• Choledochitis
• Liver fluke infections

Cholangiocarcinoma must be differentiated from other diseases such as:

For an intrahepatic mass-forming cholangiocarcinoma consider:

• Liver metastases

• Central necrosis (high T2 signal) is more common

• Hepatocellular carcinoma (HCC)

• Tumor thrombus more common
• Capsular retraction uncommon
• May appear very similar

• Other primary liver tumors
• Hepatic abscess

For a periductal infiltrating cholangiocarcinoma consider:

• Benign stricture

• Usually short-segment
• Regular margin
• Symmetric narrowing
• No ductal enhancement
• No lymph node enlargement
• No periductal soft-tissue mass

• Periportal lymphangitic metastasis

For an intraductal cholangiocarcinoma consider:

• Intraductal invasion by a HCC

• Extraductal mass

• Hepatolithiasis

• No enhancement
• Higher attenuation

• Biliary cystadenoma or cystadenocarcinoma

• Intratumoural cysts do not communicate with the biliary tree

• Benign stricture